Exercise intolerance in a man with ischaemic cardiomyopathy and biventricular pacing

Bevan,G. H.,Buber,J.
DOI: https://doi.org/10.1136/heartjnl-2024-324056
IF: 5.7
2024-04-26
Heart
Abstract:Clinical introduction A patient in his 60s with a history of ischaemic cardiomyopathy and severely reduced left ventricular ejection fraction of 20% presents with worsening dyspnoea on exertion. He is tolerating therapeutic doses of guideline-directed medical therapy including sacubitril-valsartan, carvedilol, spironolactone and empagliflozin, and has a biventricular implantable cardiac defibrillator. He undergoes cardiopulmonary exercise testing (CPET) using the treadmill-modified Bruce protocol and is found to have a severely reduced peak oxygen consumption (VO 2 ) (14.9 mL/kg/min) despite maximal effort. The test was stopped due to shortness of breath. Plots 1 and 2 from the CPET are shown in figure 1A and B. Figure 1 (A) Oxygen consumption (VO 2 ) (empty red squares) and carbon dioxide production (VCO 2 , blue dots). (B) Heart rate (HR) (beats per minute, brown dots) and oxygen pulse (VO 2 /HR, empty red squares). Question What is the most likely...
cardiac & cardiovascular systems
What problem does this paper attempt to address?